Molecular biomarkers for lung adenocarcinoma

Olivier Calvayrac, Anne Pradines, Elvire Pons, Julien Mazières, Nicolas Guibert

Source: Eur Respir J , 49 (4)  1601734; DOI: 10.1183/13993003.01734-2016
Journal Issue: April

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Olivier Calvayrac, Anne Pradines, Elvire Pons, Julien Mazières, Nicolas Guibert. Molecular biomarkers for lung adenocarcinoma. Eur Respir J , 49 (4)  1601734; DOI: 10.1183/13993003.01734-2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Molecular abnormalities and histopathology in lung cancer
Source: ERS Research Seminar
Year: 2015

Molecular markers in non-small cell lung carcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 86s
Year: 2006

Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015

Molecular imprint of lung cancer development
Source: ERS Lung Science Conference 2017
Year: 2017

Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013

Molecular hallmarks of smoking in the Gauting lung adenocarcinoma donors
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020


Molecular biologic characterization of operated non-small cell lung cancer according to smoking history
Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients
Year: 2008


Significance of expression of TGF-β in pulmonary metastasis in non-small cell lung cancer tissues
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015

Metabolomics in lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: ERS Lung Science Conference 2017
Year: 2017

Molecular and clinical profile of adenocarcinoma lung among Indian women
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017


Validation of diagnostic molecular markers in bronchial fluid for lung cancer
Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer
Year: 2011


Molecular epidemiology in non small cell lung cancer (NSCLC) tumors: implication of gender and histological features
Source: Eur Respir J 2006; 28: Suppl. 50, 335s
Year: 2006

Identification of tumor-associate proteins in stage-I lung squamous cancer by proteomics
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013


Multi-omic molecular profiling of lung cancer in COPD
Source: Eur Respir J, 52 (1) 1702665; 10.1183/13993003.02665-2017
Year: 2018